Mónica Ortego
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases 3
- Cancer Research top 5%
- NF-κB Signaling Pathways 3
- Cancer, Lipids, and Metabolism 2
-
- Antiplatelet Therapy and Cardiovascular Diseases 2
- Surgery top 5%
- Lipoproteins and Cardiovascular Health 7
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 5
-
- Cytokine Signaling Pathways and Interactions 3
-
- Plant biochemistry and biosynthesis 2
- Co-authors
- Jesús EgidoMiguel Ángel Hernández-PresaCarmen BustosGonzalo HernándezJosé TuñónLuis Miguel Blanco‐ColioLuís OrtegaC. Díaz
- Partner nations
- SpainUnited States
In The Last Decade
Mónica Ortego
19 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 96
- Immunology 618
- Cancer Research 427
- Cardiology and Cardiovascular Medicine 616
- Surgery 939
- Pharmacology 262
Countries citing papers authored by Mónica Ortego
This map shows the geographic impact of Mónica Ortego's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mónica Ortego with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mónica Ortego more than expected).
Fields of papers citing papers by Mónica Ortego
This network shows the impact of papers produced by Mónica Ortego. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mónica Ortego. The network helps show where Mónica Ortego may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mónica Ortego, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2014 | 10 | |
| 3 | 2008 | 26 | |
| 4 | 2006 | 46 | |
| 5 | 2005 | 26 | |
| 6 | 2005 | 75 | |
| 7 | 2003 | 63 | |
| 8 | Total fatty acid quantification as an estimator of total body fat content in broilers fed unsaturated diets. | 2003 | 4 |
| 9 | 2002 | 173 | |
| 10 | 2002 | 11 | |
| 11 | 2002 | 110 | |
| 12 | 2000 | 116 | |
| 13 | 2000 | 2 | |
| 14 | 1999 | 309 | |
| 15 | 1998 | 354 | |
| 16 | 1998 | 99 | |
| 17 | 1998 | 332 | |
| 18 | 1997 | 425 | |
| 19 | 1997 | 1 | |
| 20 | 1996 | 140 |
About Mónica Ortego
Mónica Ortego is a scholar working on Cancer Research, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 20 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (7 papers), Inflammatory mediators and NSAID effects (5 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), NF-κB Signaling Pathways (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Plant biochemistry and biosynthesis (2 papers). The work is most often cited by research in Immunology (618 citations), Cancer Research (427 citations) and Cardiology and Cardiovascular Medicine (616 citations). Mónica Ortego has collaborated with scholars based in Spain and United States. Frequent co-authors include Jesús Egido, Miguel Ángel Hernández-Presa, Carmen Bustos, Gonzalo Hernández, José Tuñón, Luis Miguel Blanco‐Colio, Luís Ortega, C. Díaz, Juan José González Plaza and Marta Ruiz‐Ortega.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.